Purchase Order 75N98026P00186
Award Date 4/1/26
Potential Completion Date 3/31/27
Potential Value $67K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart, Lung and Blood Institute of the National Institutes of Health, part of the Department of Health and Human Services, has awarded a $99,840 firm fixed price purchase order to Ozgene PTY LTD of Australia. Under this contract, Ozgene will provide creation of HBB, HBBS, and HBBE knock-in mice to the NIH over the course of one year, from July 2023 through July 2024. The mice will support research into hemoglobin disorders and red blood cell development, advancing the NIH's...
- This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
- This federal contract award is for a mouse colony breeding service to support an ongoing project involving transgenic hemoglobin mice at Ozgene, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, and has a ceiling value of $21,267.00 under a firm fixed price purchase order. The...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company. The contract, valued at $67,700.00, is for the provision of genetically modified mice and rats to support biomedical research. The contract does not have a set-aside designation. Ozgene, the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
- This is a delivery order worth $2,244 awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), and did not utilize a set-aside designation. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
- This federal contract award is for Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $6,193.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is a delivery order for the production of gene knockout and gene knock-in male mice to be crossed with female...